Colin MacKay, CEO of Symbiosis Pharmaceutical Services, recently took part in a Q&A interview with BioPharma-Reporter, discussing how increased manufacturing demand for cell and gene therapies is driving the growth of the viral vector supply market and the challenges that are still to be addressed.The growing prevalence of cell and gene therapies in both the clinical and the commercial side of the… Read More
Stirling, UK – Fast-growing specialist sterile manufacturing and Contract Manufacturing Organisation (CMO) Symbiosis Pharmaceutical Services (Symbiosis), has expanded its sterile biologics manufacturing facility in Scotland, UK by 25%.In the last 12 months Symbiosis has invested over £1.5m ($1.9m) in the expansion of its Stirling site, doubling its current footprint with an additional 8,000 sq ft of office space to house the firm’s… Read More